SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice. / Emanuelli, Brice; Peraldi, Pascal; Filloux, Chantal; Chavey, Carine; Freidinger, Kathryn; Hilton, Douglas J.; Hotamisligil, Gökhan S.; Van Obberghen, Emmanuel.

In: Journal of Biological Chemistry, Vol. 276, No. 51, 21.12.2001, p. 47944-47949.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Emanuelli, B, Peraldi, P, Filloux, C, Chavey, C, Freidinger, K, Hilton, DJ, Hotamisligil, GS & Van Obberghen, E 2001, 'SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice', Journal of Biological Chemistry, vol. 276, no. 51, pp. 47944-47949. https://doi.org/10.1074/jbc.M104602200

APA

Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, D. J., Hotamisligil, G. S., & Van Obberghen, E. (2001). SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice. Journal of Biological Chemistry, 276(51), 47944-47949. https://doi.org/10.1074/jbc.M104602200

Vancouver

Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ et al. SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice. Journal of Biological Chemistry. 2001 Dec 21;276(51):47944-47949. https://doi.org/10.1074/jbc.M104602200

Author

Emanuelli, Brice ; Peraldi, Pascal ; Filloux, Chantal ; Chavey, Carine ; Freidinger, Kathryn ; Hilton, Douglas J. ; Hotamisligil, Gökhan S. ; Van Obberghen, Emmanuel. / SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 51. pp. 47944-47949.

Bibtex

@article{eddb25ec7a184bc7ade5f4e7ef1e0c9d,
title = "SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice",
abstract = "SOCS (suppressor of cytokine signaling) proteins are inhibitors of cytokine signaling involved in negative feedback loops. We have recently shown that insulin increases SOCS-3 mRNA expression in 3T3-L1 adipocytes. When expressed, SOCS-3 binds to phosphorylated Tyr960 of the insulin receptor and prevents Stat 5B activation by insulin. Here we show that in COS-7 cells SOCS-3 decreases insulin-induced insulin receptor substrate 1 (IRS-1) tyrosine phosphorylation and its association with p85, a regulatory subunit of phosphatidylinositol-3 kinase. This mechanism points to a function of SOCS-3 in insulin resistance. Interestingly, SOCS-3 expression was found to be increased in the adipose tissue of obese mice, but not in the liver and muscle of these animals. Two polypeptides known to be elevated during obesity, insulin and tumor necrosis factor-α (TNF-α), induce SOCS-3 mRNA expression in mice. Insulin induces a transient expression of SOCS-3 in the liver, muscle, and the white adipose tissue (WAT). Strikingly, TNF-α induced a sustained SOCS-3 expression, essentially in the WAT. Moreover, transgenic ob/ob mice lacking both TNF receptors have a pronounced decrease in SOCS-3 expression in the WAT compared with ob/ob mice, providing genetic evidence for a function of this cytokine in obesity-induced SOCS-3 expression. As SOCS-3 appears as a TNF-α target gene that is elevated during obesity, and as SOCS-3 antagonizes insulin-induced IRS-1 tyrosine phosphorylation, we suggest that it is a player in the development of insulin resistance.",
author = "Brice Emanuelli and Pascal Peraldi and Chantal Filloux and Carine Chavey and Kathryn Freidinger and Hilton, {Douglas J.} and Hotamisligil, {G{\"o}khan S.} and {Van Obberghen}, Emmanuel",
year = "2001",
month = dec,
day = "21",
doi = "10.1074/jbc.M104602200",
language = "English",
volume = "276",
pages = "47944--47949",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "51",

}

RIS

TY - JOUR

T1 - SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice

AU - Emanuelli, Brice

AU - Peraldi, Pascal

AU - Filloux, Chantal

AU - Chavey, Carine

AU - Freidinger, Kathryn

AU - Hilton, Douglas J.

AU - Hotamisligil, Gökhan S.

AU - Van Obberghen, Emmanuel

PY - 2001/12/21

Y1 - 2001/12/21

N2 - SOCS (suppressor of cytokine signaling) proteins are inhibitors of cytokine signaling involved in negative feedback loops. We have recently shown that insulin increases SOCS-3 mRNA expression in 3T3-L1 adipocytes. When expressed, SOCS-3 binds to phosphorylated Tyr960 of the insulin receptor and prevents Stat 5B activation by insulin. Here we show that in COS-7 cells SOCS-3 decreases insulin-induced insulin receptor substrate 1 (IRS-1) tyrosine phosphorylation and its association with p85, a regulatory subunit of phosphatidylinositol-3 kinase. This mechanism points to a function of SOCS-3 in insulin resistance. Interestingly, SOCS-3 expression was found to be increased in the adipose tissue of obese mice, but not in the liver and muscle of these animals. Two polypeptides known to be elevated during obesity, insulin and tumor necrosis factor-α (TNF-α), induce SOCS-3 mRNA expression in mice. Insulin induces a transient expression of SOCS-3 in the liver, muscle, and the white adipose tissue (WAT). Strikingly, TNF-α induced a sustained SOCS-3 expression, essentially in the WAT. Moreover, transgenic ob/ob mice lacking both TNF receptors have a pronounced decrease in SOCS-3 expression in the WAT compared with ob/ob mice, providing genetic evidence for a function of this cytokine in obesity-induced SOCS-3 expression. As SOCS-3 appears as a TNF-α target gene that is elevated during obesity, and as SOCS-3 antagonizes insulin-induced IRS-1 tyrosine phosphorylation, we suggest that it is a player in the development of insulin resistance.

AB - SOCS (suppressor of cytokine signaling) proteins are inhibitors of cytokine signaling involved in negative feedback loops. We have recently shown that insulin increases SOCS-3 mRNA expression in 3T3-L1 adipocytes. When expressed, SOCS-3 binds to phosphorylated Tyr960 of the insulin receptor and prevents Stat 5B activation by insulin. Here we show that in COS-7 cells SOCS-3 decreases insulin-induced insulin receptor substrate 1 (IRS-1) tyrosine phosphorylation and its association with p85, a regulatory subunit of phosphatidylinositol-3 kinase. This mechanism points to a function of SOCS-3 in insulin resistance. Interestingly, SOCS-3 expression was found to be increased in the adipose tissue of obese mice, but not in the liver and muscle of these animals. Two polypeptides known to be elevated during obesity, insulin and tumor necrosis factor-α (TNF-α), induce SOCS-3 mRNA expression in mice. Insulin induces a transient expression of SOCS-3 in the liver, muscle, and the white adipose tissue (WAT). Strikingly, TNF-α induced a sustained SOCS-3 expression, essentially in the WAT. Moreover, transgenic ob/ob mice lacking both TNF receptors have a pronounced decrease in SOCS-3 expression in the WAT compared with ob/ob mice, providing genetic evidence for a function of this cytokine in obesity-induced SOCS-3 expression. As SOCS-3 appears as a TNF-α target gene that is elevated during obesity, and as SOCS-3 antagonizes insulin-induced IRS-1 tyrosine phosphorylation, we suggest that it is a player in the development of insulin resistance.

UR - http://www.scopus.com/inward/record.url?scp=0035930605&partnerID=8YFLogxK

U2 - 10.1074/jbc.M104602200

DO - 10.1074/jbc.M104602200

M3 - Journal article

C2 - 11604392

AN - SCOPUS:0035930605

VL - 276

SP - 47944

EP - 47949

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -

ID: 200864590